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Abstract
Background: Many physiological processes within the human body can be perceived and modeled as large
systems of interacting particles or swarming agents. The complex processes of the human immune system prove
to be challenging to capture and illustrate without proper reference to the spacial distribution of immune-related
organs and systems. Our work focuses on physical aspects of immune system processes, which we implement
through swarms of agents. This is our first prototype for integrating different immune processes into one
comprehensive virtual physiology simulation.
Results: Using agent-based methodology and a 3-dimensional modeling and visualization environment (LINDSAY
Composer), we present an agent-based simulation of the decentralized processes in the human immune system.
The agents in our model - such as immune cells, viruses and cytokines - interact through simulated physics in two
different, compartmentalized and decentralized 3-dimensional environments namely, (1) within the tissue and
(2) inside a lymph node. While the two environments are separated and perform their computations
asynchronously, an abstract form of communication is allowed in order to replicate the exchange, transportation
and interaction of immune system agents between these sites. The distribution of simulated processes, that can
communicate across multiple, local CPUs or through a network of machines, provides a starting point to build
decentralized systems that replicate larger-scale processes within the human body, thus creating integrated
simulations with other physiological systems, such as the circulatory, endocrine, or nervous system. Ultimately, this
system integration across scales is our goal for the LINDSAY Virtual Human project.
Conclusions: Our current immune system simulations extend our previous work on agent-based simulations by
introducing advanced visualizations within the context of a virtual human anatomy model. We also demonstrate
how to distribute a collection of connected simulations over a network of computers. As a future endeavour, we
plan to use parameter tuning techniques on our model to further enhance its biological credibility. We consider
these in silico experiments and their associated modeling and optimization techniques as essential components in
further enhancing our capabilities of simulating a whole-body, decentralized immune system, to be used both for
medical education and research as well as for virtual studies in immunoinformatics.
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Background
Recent years have witnessed a growing interest in systems
biology [1-7]. Not only are biological systems themselves
better understood, but increased computational power,
visualization environments and more readily available dis-
tributed computing enhance the value of modeling and
simulation. In the literature so far, there has been little con-
cern regarding more sophisticated visualizations in scienti-
fic modeling. Noteworthy efforts in this direction include
Harvard’s BioVisions project [8]. We take the viewpoint,
that simulations should involve a high degree of visual rea-
lism; visualization then becomes a key part of our model-
ling approaches. We present our latest 3-dimensional
simulations and interactive visualizations of the decentra-
lized processes in the human immune system.
Using agent-based approaches in simulations is another
aspect to increase realism in computer simulations. Rules
or simple programs and attributes for agents can then
drive the overall dynamics of a system of interacting enti-
ties, which result in emergent observable patterns [9,10].
An agent-based approach allows simulations to incorpo-
rate computational versions of the physical interaction
rules that are observed directly in nature. While the agent-
based approach does not replace traditional mathematical
modeling [11], it rather acts as a strong complement for
better understanding complex biological phenomena.
Furthermore, coupling agent-based simulations with
advanced graphics visualization and intuitive interaction
interfaces can appeal greatly to life scientists, who do not
have a programming background or any interest in learn-
ing new modeling environments. Allowing such biology
experts to appreciate the value of computer simulations is
key to the advancement and wider acceptance of systems
biology [2,7,12]. Finally, making virtual experiments more
accessible to biologists, immunologists, and medical
researchers will facilitate answers to particularly those
research questions not achievable through purely labora-
tory means.
In this work, we present our latest simulation of the
decentralized processes of the human immune system
[10,13]. Our simulation consists of different compart-
mentalized regions – simulated as agent environments –
communicating with one another to produce high-level
emergent effects such as an organism’s immunity to
harmful pathogens. Each compartment consists of large
numbers of agents, with relatively simple behavioural
rules, that act collectively in highly sophisticated net-
works of interactions. We chose the common Influenza
A virus infection as the base for our immune system
simulation.
Adaptive immune system
The adaptive immune response results in the elimination
of various pathogens such as viruses and other foreign
particles. It is also responsible for developing a memory
response for future infections with the same antigens.
The mechanism through which humans develop immu-
nity to disease-causing pathogens is through the cellular
interactions of two different branches of immunity:
(1) humoral and (2) cell-mediated. Humoral immunity
acts via the production and secretion of antibodies which
neutralize harmful antigens. On the other hand, cell-
mediated immunity functions via the destruction of
infected cells, in order to suppress any further spreading
of a virus. Both branches have the ability to create mem-
ory cells that can prevent secondary infections with pre-
viously encountered viruses [12].
Lymphocytes have a very important role in the adaptive
immune system: T cells are responsible for cell-mediated
immunity and B cells are responsible for humoral immu-
nity. T cells and B cells are mainly found throughout the
different lymphatic organelles, where they are most likely
to encounter antigens. Both types of lymphocytes have
antigen-specific receptors on their surface that allows
them to detect specific antigen molecules. The binding of
an antigen to a naive lymphocyte results in the lympho-
cyte becoming an effector cell, a cell that is directly
involved in the immune response.
The infection is initially detected by professional anti-
gen-presenting cells such as macrophages and dendridic
cells that are nearby. Upon detection, the antigen-bearing
cells migrate to nearby lymph nodes to trigger the
immune response. Within the lymph nodes, B cells and
T cells interact with the antigen-presenting cells as well
as free antigen molecules. Some activated T cells, namely
the cytotoxic T cells, travel to the tissue to eliminate
infected cells, while a subpopulation, called helper
T cells, remain in the lymph node to promote further
proliferation of nearby lymphocytes. B cells that develop
into plasma cells produce large amounts of antibodies,
which travel via the blood stream to the site of infection
in order to neutralize virus particles. Neutralization
involves the blocking of surface receptors on a virus
responsible for entry into a healthy cell. After the infec-
tion is successfully defended, some B and T cells remain
in the body as long lived memory cells. Upon secondary
exposure to the same virus, the memory cells can quickly
divide and mobilize to form a swift response, eliminating
the virus before any serious effects are noticed by the
host organism [14-17].
Immune response to influenza A infection
Influenza A is a member of the Orthomyxoviridae family
of viruses which affect humans, other mammals and some
species of birds. The virus is generally transmitted from
infected individuals through the air via coughs or sneezes
and infects the epithelial cells lining the lung and throat.
The Influenza A virus multiplies by utilizing the host cell’s
own replication and protein synthesis machinery to
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produce copies of the virus, which spread out to infect
more tissue [18]. Figure 1 illustrates the airborne Influenza
a virus in the context of our virtual human model, which
is the basis for our simulation.
Modeling and simulating the human immune system
Natural immune system processes have been inspira-
tional for the modeling of adaptive and learning systems
in the field of artificial intelligence [19,20]. We do not
Figure 1 Virus entry. The computer model with the airborne Influenza A virus in the context of the LINDSAY Virtual Human model. This
diagram illustrates the entry of the virus via the nasal cavity (a), into the upper respiratory tract of a host (b). The green shapes represent lymph
nodes in the vicinity of the upper respiratory tract (c).
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consider these machine learning aspects here. Mathema-
tical models, based on differential equations, have been
used to simulate changes of concentrations of immune
system agents and large-scale regulatory and defensive
actions of the immune system [11,12,21]. Lee et al. [22]
provide a comprehensive mathematical model of the
specifics of Influenza A Infection. They also divide their
system into compartments: the lung and the lymphatic
system. Communication between compartments is
implicit in their mathematical model as there is no dif-
ference in scale or any concrete notion of location and
distance. While mathematical models do provide accu-
rate results and some conceptual understanding of the
overall dynamics, they lack interactive visualizations and
are not easily expandable for larger, more integrative
systems.
Agent-based modeling, in the form of cellular automata
has been used to simulate the processes of the immune
system [23]. This work is extended in [24] by introducing
cell-mediated interactions to a purely humoral immunity
model.
Jacob et al. [10] present an immune system simulation
using the concept of virtual swarms, where simple, yet
large numbers of particles interact in 3-dimensional sce-
narios. This work is built upon in [13], where different
compartments across an abstracted human body are intro-
duced. Similar to our work, simple agent rules are used to
create complex interaction networks across different com-
partments connected through a data exchange channel.
What we have added in the simulations we discuss in this
paper are (1) more advanced visualizations, (2) physics-
based models that drive agent interactions, and (3) run-
ning our immune system models within a 3-D virtual
anatomy model of a human male.
For programming the behaviours and properties of
agents we use an object-oriented architecture. In this
approach, objects can have internal information (such as
states) and are able to send and receive certain messages.
Furthermore, the inheritance model is of high importance
as it allows common behaviors, such as cell motility, to be
implemented at a higher level and shared by the sub-class
implementations of the different types of individual cells.
Bersini provides some insight of how to use object-
oriented programming to build the different agents of the
human immune system [25].
Integrating different models across many levels of scale
is beginning to eliminate what most researchers consider
the “bottom-up” approach, where systems are built from
atomic parts. In the “bottom-up” approach systems
become problematic when attempting to model a realistic
process, because of the extremely large number of entities
that simultaneously interact. As suggested by Noble [26],
building such multi-scale models “middle-out” seems to
be a more feasible approach. By creating a connected
multi-scale system, changes in a process (such as an infec-
tion) can ripple across the different levels of abstraction,
to inform the whole system efficiently. The Multiscale Sys-
tems Immunology (MSI) project attempts to model the
immune response over many different levels of temporal
and spatial scales [27] and has been inspirational for our
multi-scale models.
Methods
As part of the LINDSAY Virtual Human project [28], we
are developing a 3-dimensional, interactive computer
model of male and female anatomy and physiology to be
used for medical education. One key characteristic of
LINDSAY is the integration of computational models
across scales in order to simulate physiological processes
from the body level to the level of organs, tissues, cells,
and sub-cellular structures. This is similar to the Physiome
project [29,30], yet our main focus is on medical education
with a high degree of interactivity for our simulations, ren-
dered in 3-D, and live navigation across scales (Figure 2).
LINDSAY composer modeling environment
LINDSAY Composer (LC) [31] is a software suite for creat-
ing hierarchical 3-D models and visualizations. The mod-
eling environment consists of a collection of component
engines for physics, graphics, cameras, user interaction,
and agent behaviour rules. Each engine is responsible for
controlling the execution of its respective components at
each step of the simulation. Component engines can be
split into two groups: native engines and external engines.
Native engines, such as the physics and graphics engines,
are always present within the LC framework. In the model
discussed here, the Immune System simulation is built as
a plug-in to LINDSAY Composer with its own engine
loaded at start-up.
The Lindsay Composer allows a user to construct and
add objects to a simulation using a static component
library. The component library contains templates of
possible agents and other controllers which can interact
with the current simulation. Figure 3 illustrates how one
can drag a virus particle from the component library
onto an epithelial cell to cause infection.
Entities simulated by the LC are represented as hierar-
chies of components that define their respective states
and behaviors. For example, Figure 4 illustrates the
component hierarchy for an epithelial cell, in diagram-
matic representation and how this organizational struc-
ture is accessible through the LC user interface. In the
component hierarchy, we see that an epithelial cell com-
ponent consists of five child components, of which one
is nested:
- ImmuneSystem_EpithelialCell defines the state and
interaction rules of the epithelial cell agent.
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Figure 2 Anatomical context of the simulation within the LINDSAY composer. Within the LINDSAY simulation environment, one can
represent different simulations within their correct anatomical contexts. This figure depicts the views as a result of interactive zooming from a
high level of abstraction to a lower, more fine grained scale. In the multi-scale LINDSAY Virtual Human environment, different simulations can be
represented within the anatomical context of interest.
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- LCTransformComponent defines the location, size
and orientation of the agent in 3-dimensional space.
- LCSphereGhostObject allows the agent to be aware
of other physics objects inside the radius of the
ghost object, which is used to create a virtual aware-
ness space around an object. This object contains a
child–the ImmuneSystem_AttractionField compo-
nent– which attracts certain other agents (such as
viruses) towards the current epithelial cell.
- OEMeshNode gives the agent a graphical represen-
tation, which contains a 3-dimensional mesh, tex-
tures, colours, shadows and animations.
- LCRigidBodySphere contains all of the physics
related information such as mass, acceleration and
collision shape.
The human immune system encompasses processes
across a wide range of scale: starting with the organismal
level, one can integrate interaction processes at the organ
level (e.g., inside the thymus), at the tissue level (e.g., inside
lymph nodes), at the intra-cellular interaction level (e.g.,
between bacteria and macrophages) and, finally, at the
inner-cell processes such as protein synthesis and gene
regulation. The LC framework allows the developer to
integrate different modeling techniques across multiple
scales (Figure 2) into one comprehensive model. In the
case of the immune system, the simulations at a higher
level of scale would include the bone marrow, thymus,
lymphatic system and circulatory system, while the simula-
tion at a lower scale would represent individual lymph
nodes, site of infection and the process of inflammation.
Agent-based model of the human immune system
The agents in our current immune system model are:
epithelial cells, viruses, antibodies, B cells, T cells, macro-
phages and dendridic cells (Figure 5). The behavior of
the agents is dictated by sets of rules as well as their
internal states. For example, an epithelial cell can be
either infected or not infected. Similarly, a virus may be
active or opsonized. The state of each cell changes
dependent on what interactions it experiences with the
other agents as well as the current state of the environ-
ment. The agent interactions we have implemented are
illustrated in Figure 6.
Due to current computational limitations, it is impossi-
ble to construct agent-based simulations that represent
the exact number of entities found in nature. Therefore,
we employed some constraints on our agents to simulate
qualitatively correct interactions on a large scale with only
a limited number of agents (in our case a few thousand).
Figure 3 Drag-and-drop interface. Using the simple drag-and-drop interface of the LC to infect a cell with a virus particle from the
component library (left). The dragging feature is implemented by ray-tracing in 3D space to detect surfaces directly underneath the mouse
cursor.
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Figure 4 Component view of an agent. Illustration of the component hierarchy for an agent. The bottom hierarchy represents the object
inheritance map of the “ImmuneSystem EpithelialCell” component, with its own attributes aside from those inherited from super components.
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Since we have such a relatively small number of agents,
the chance that two agents will collide randomly is low.
Therefore, all our agents have attraction spheres around
their actual physical meshes. This allows agents in close
proximity to have a higher chance of becoming aware of
and interacting with each other. For example, an epithelial
cell can attract a virus, and similarly, a virus can attract an
antibody (illustrated in Figure 7). T cells, B cells and
macrophages also have their respective attraction fields.
Once in an attraction field, an agent a will break out of
the attraction with probability ∅break(a) to ensure that
overall stochastic motion is preserved. This approach gave
us more reproducible results over multiple simulations,
rather than basing the physical interactions solely on ran-
dom motion.
Lung tissue
The simulated lung tissue consists of approximately 200
epithelial cells. The cells are not statically placed in an
aligned fashion, but rather allowed to reproduce and
arrange themselves based on physical interactions
(Figure 8). The dynamic self-arrangement of the cells
allows our simulation to be bound by any arbitrary shape
– such as a vessel – instead of simply a square arrange-
ment. Replication is triggered if the cell has enough energy
and the neighbor count is less than 4 adjacent cells, that is
there is still enough space to replicate.
Epithelial cells (Î) are susceptible to be infected by an
Influenza A Virus (v) with a given probability pint(Î,v)
upon direct mesh-to-mesh collision. After infection, the
cell lives for another Îincubation = 200 iterations, fol-
lowed by cell death and subsequent release of Îvirusesre-
leased = 5 new virus particles. In addition, the lung tissue
contains 12 initial immature dendridic cells residing in
the tissue. These cells become activated upon contact
with viral particles, and are able to migrate to the lymph
nodes to activate the B and T lymphocytes.
Figure 5 Immune system agents. The types of agents in our model (here not depicted to scale): antibody (a), virus (b), epithelial cell (c), B cell (d),
















































Figure 6 Agent interaction rules. Diagram of agent interactions of our immune system model. Coloured arrows represent the different types
of interactions between agents.
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Lymph node
The simulated lymph node is initialized with 15 naive B
and 15 naive T cells. When there is no infection detected,
the cells maintain a constant population over time. B
cells also have a phenotypic signature – represented in
our model as a 16-bit integer – for immunity against a
specific antigen (Figure 9). We define a matching signa-
ture which complements the viral signature bit-by-bit
(Figure 9). The affinity of an antibody signature to that of
a virus is calculated using the XNOR binary operator. In
the beginning, no B cells have the same signature as the
virus, this is acquired through multiple stages of division
and clonal selection. Through division, B cells have a ran-
dom chance to get assigned a new antigenic signature.
The B cells that have a high affinity to the viral signature,
have a lesser chance to die and higher chance of repro-
duction. The opposite is true for the B cell that have a
low affinity to the viral signature. Those that match he
viral signature proceed to divide and release antibodies
into the environment. A percentage of the cells that divide
from activated B cells become memory B cells and live
throughout the entire simulation. The same mechanism
for clonal selection is applied to T cells. Some T cells
become helper T cells that promote proliferation of B cells
and other T cells within the lymph node.
Simulation distribution
Our experiments look at two different compartments of the
human immune system that are able to communicate and
coordinate asynchronously. The simulation of the lymph
node is executed on a different computing node than the
tissue simulation. Our developed protocol allows us to
build large networks of simulation nodes working together
to form a large-scale distributed simulation system. The
network setup as well as the communication between the
tissue and the lymph node are controlled through distribu-
ted objects (from the Cocoa Objective-C Library), which
not only work over a network but also between threads and
CPUs, whether on the same computer or not. Therefore,
the system is not restricted to one simulation per machine,
but rather one simulation per computing core over a large
network, which maximizes efficiency with respect to mes-
sage exchange.
In our simulation, the information exchanged between
the lymph node and tissue is rather basic. The lymph
node distributed controller feeds its agent numbers and
properties to other controllers that are connected to it.
Since the tissue is connected, it will get informed of
changes in numbers of certain agents that it is interested
in. For example, the tissue controller is interested in
knowing about the number of B cells, T cells and antibo-
dies produced in the lymph node. On the other hand, the
lymph node controller is interested in the number of
contacts of dendridic cells with viral particles and acti-
vated antigen presenting cells in the tissue. At each simu-
lation step, the respective controllers broadcast their
current states over the network, allowing asynchronous
coordination. Figure 10 illustrates the exchange of infor-
mation between a lymph node distributed controller and
a tissue distributed controller.
The information received by each distributed control-
ler affects the state of the simulation environment or, in
Figure 7 Agent attraction. A snapshot of the attraction between a virus particle and antibodies. Upon contact with the antibody, the virus is
neutralized. The bounded green area (ghost object) around the virus represents the invisible attraction sphere.
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this case, the state of the immune system engine of the
respective simulation. The agents controlled by the
engine are then able to use the new state provided by
the engine to inform their decisions, aside from their
current physical interactions.
The distributed approach to our system of simulation
is highly flexible for extending it over multiple scales.
The distributed controllers are not restricted to commu-
nicating across simulations of the same type, but can
connect data from simulations over multiple scales. For
example, one can introduce a differential equation-based
model of lymphocyte growth and development in the
bone marrow and link it to the agent population in the
circulation and in the lymph nodes.
Limitations
A limitation of our system lies in different time offsets
that can arise from a distributed simulation. Presently,
at each distributed controller we make no adjustment
Figure 8 Epithelial cell division. Illustration of natural division of epithelial cells. The decision to divide is dependent on the number of
neighbours adjacent to each epithelial cell.
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with regard to time. That is, if a node is slowing down
(e.g., due to limited computing resources) the other
nodes connected to it still run at their normal rates.
The discrepancy is somewhat accounted for in the fact
that the slow node does not receive any updates, and
therefore does not broadcast any updates outside of its
own rate of execution. This stabilizes the system such
that the nodes that require information receive the
information more slowly, thus eventually matching the
same “simulation” speed as the slowest node. It is worth
noting that the “simulation” speed is not the frame rate
or execution time, but rather how fast certain events
happen inside the context of the simulation.
Results and discussion
Table 1 summarized all the biological parameters that





Figure 9 Antigen and antibody signature. Illustration of the viral
and antibody 16-bit signature. In this figure, the antibody signature
perfectly complements the virus signature.
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Figure 10 Information exchange between distributed controllers. Illustration of the communication between different distributed controllers over a
network. In this figure, we show the interaction between a lymph node distributed controller and a tissue distributed controller. This can be extended
to include any number of distributed controllers communicating with each other, that can represent other immune system processes at different scales.
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parameters have been set in order to reflect the correct
biological behaviours as much as possible.
Figures 11, 12 and 13 provide an overview of the over-
all simulation. In Figure 11a figure the virus is introduced
to a few cells on the edge of the tissue. The infection then
spreads through the tissue and causes significant damage.
At the same time, lymphocytes have begun the selection
process (Figure 11b). Once the correct signature
Figure 11 Visualization of the immune response to influenza A infection (Part 1). Agent interactions in both tissue (left) and lymph node
(right) as a result of infection with the Influenza A virus. (a) The virus has just infected the tissue cells into the lung, where red cells represent
infected cells. At the same time, there is not yet any immune activity in the lymph node. (b,c) As the infection progresses, the immune response
can be observed both in the tissue (cell-mediated) and in the lymph node (humoral).
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(encoded as a 16-bit integer) has been found, the B cells
and T cells proliferate at a rapid rate. Several cytotoxic T
cells can be observed at the site of infection as well as an
increased number of macrophages. The antibody pro-
duced in the lymph node is transported to the tissue in
order to neutralize the virus. Once the infection has been
cleared, the tissue regenerates and the lymph node ceases
immune activity. Long lived and memory lymphocytes
remain in circulation for a long time after the initial
infection.
Figure 12 Visualization of the immune response to influenza A infection (Part 2). (d,e) The initial infection is eliminated and the simulation
reaches a steady state. (f) We reintroduce the virus into the tissue. Infected epithelial cells are depicted in red.
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We performed 20 simulation runs using the parameters
in Table 1, with the results illustrated in Figure 14. We
included error bars to illustrate the stochastic nature of
our simulations. While there is significant variation over
the different simulations, the outcome and overall
behavior is consistent. None of the simulations resulted
in a complete destruction of the tissue nor in hyperactiv-
ity of the immune system. We compare our results to a
robust and comprehensive mathematical model of the
Influenza A infection, described in [22]. Considering the
Figure 13 Visualization of the immune response to influenza A infection (Part 3). A large immune reaction to occur in a short amount of
time (g,h,i), as a result of reintroducing the virus into the tissue.
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relatively low numbers of agents as well as the stochastic
nature of our simulation, our results (Figure 14) agree
with those obtained in [22].
To test the adaptive capabilities of our immune system
model, we re-introduce the same virus into the tissue after
the initial infection has been cleared (time step 8000 in
one of our experiments in Figure 14). A rapid response
from the lymph node can be observed due to the memory
lymphocytes (Figure 13h). While the virus still spreads
through the tissue during the second exposure, there is
not as much observable damage, as the virus is eliminated
much faster than before. The overall adaptive response is
illustrated in Figure 15, where one can see a clear distinc-
tion between the first and second immune response to the
Influenza A virus. The overall adaptive behavior of our
model is similar to that described in immunology text-
books [32,33]. Not only is the maximum number of
viruses less during second exposure, but the damage to
the tissue is significantly less than during the first expo-
sure. The cell-mediated reactions start much faster but are
not as intense during second exposure as the virus is
eliminated more quickly.
Conclusions and future work
This paper presents our latest work on simulating the
decentralized processes of the human immune system
within the context of the LINDSAY Virtual Human.
The LINDSAY Composer environment provides a wide
array of state-of-the-art simulation techniques including








































































Figure 14 Overall immune response to influenza A infection. Influenza A infection: summary of 20 simulation runs with control parameters
as described in Table 1. The horizontal axis represents iteration time steps. The vertical axis represents the number of agents. Our simulation
runs for 6000 time steps which is equivalent to 30 days.
Sarpe and Jacob BMC Bioinformatics 2013, 14(Suppl 6):S2
http://www.biomedcentral.com/1471-2105/14/S6/S2
Page 16 of 18
interactions and intuitive live-interaction interfaces. One
of the strengths of our immune simulation is the visuali-
zation aspect, because it provides dynamic illustrations
on the essential concepts of the well-orchestrated sys-
tem of agent interactions that eventually create complex
emergent behaviour such as the acquisition of natural
immunity to harmful pathogens. We have created a fra-
mework for distributing multiple simulations over a net-
work to increase the efficiency and scalability of our
system. Our hope is that by introducing more simula-
tions that work together in a decentralized fashion, we
can achieve an advanced and well-connected network of
physiological simulations that can enhance our funda-
mental knowledge of the human body.
In order to produce agent interaction dynamics that are
close to (or even the same as) those found in natural bio-
logical processes, we are currently applying evolutionary
optimization techniques to fine tune the multitude of
parameters of our models. At this point, we have gath-
ered some preliminary, yet promising results with other
agent-based models [34].
We consider in silico experiments and their associated
modeling and optimization techniques as essential com-
ponents in further enhancing our capabilities of simulat-
ing a whole-body, decentralized immune system, to be
used both for medical education and research as well as
for virtual studies in immunoinformatics.
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Figure 15 Adaptive immune response to influenza A infection. Result of reintroducing the same virus after the initial immune response. It is
noticeable that the secondary infection with the same agent is suppressed much more effectively and the duration of the infection is reduced
as well.
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